Markets will rise on China hopes; Sun Pharma, Tata Motors, Tech Mahindra, Dilip Buildcon in news today | Jobs Vox


(Reuters) – Indian shares are set to open higher on Monday on hopes that demand in China will pick up, even as concerns about a global recession persist.

Singapore-listed NSE futures of India were up 0.30% at 18,372.50, at 7:30 am IST.

Asian markets rallied after a mixed start on hopes that demand in China would pick up, with the MSCI Asia ex Japan rising 0.3%.

Reports said China planned to increase flights to boost the recovery of its air transport market. The decision comes after the world’s second-largest economy eased several restrictions from its zero-covid-19 policy last week.

Wall Street stocks fell on Friday as weak economic data added to recession fears, with the Dow Jones losing 0.85%, the S&P 500 down more than 1% and the tech-heavy Nasdaq Composite down nearly 1%.

Limiting gains in Indian markets could be oil prices, which stabilized after a sharp decline in the previous session on optimism over the easing of COVID-19 restrictions in China. Brent oil hovered around $80 per barrel. [O/R]

The rise in oil prices is negative for oil-importing countries like India, where crude oil accounts for the bulk of the import bill.

Foreign institutional investors sold shares worth 19.75 billion rupees ($238.80 million) on a net basis on Friday, while domestic investors bought 15.42 billion rupees ($186.44 million) worth of shares, according to provisional NSE data .

** Sun Pharma: Co receives warning letter from US FDA for Halol facility.

** Tata Motors: Bengaluru Metropolitan Transport Corp signs definitive agreement with company’s unit to operate 921 electric buses.

** Tech Mahindra: Co approves sale of 100% stake in Dinacommerce Holdings BV for €6.6 million.

** Dilip Buildcon: Co wins order worth 16.47 billion rupees.

First published: 19 December 2022, 08:06 IST


Source link

Implement tags. Simulate a mobile device using Chrome Dev Tools Device Mode. Scroll page to activate.